Effect of cataract surgery on optical coherence tomography measurements and repeatability in patients with non-insulin-dependent diabetes mellitus

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 8, 2013, Pages 5303-5312

  Garcia Martin, Elena ^a,b   Fernandez, Javier ^a,b   Gil Arribas, Laura ^a,b   Polo, Vicente ^a,b   Larrosa, Jose M ^a,b   Otin, Sofia ^a,b   Fuertes, Isabel ^a,b   Pablo, Luis ^a,b  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^b INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

Author keywords

Cataract surgery; Non insulin dependent diabetes mellitus; Optical coherence tomography; Phacoemulsification; Repeatability

Indexed keywords

CREATININE; DICLOFENAC; DICLOFENACO LEPORI; GLYCOSYLATED HEMOGLOBIN; MOXIFLOXACIN; PREDNISOLONE ACETATE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CATARACT EXTRACTION; CLINICAL ARTICLE; FEMALE; GLAUCOMA; HUMAN; MACULAR THICKNESSES; MALE; MEASUREMENT REPEATABILITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; OPHTHALMOLOGY; PHACOEMULSIFICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELIABILITY; RETINA; RETINA MACULOPATHY; RETINAL NERVE FIBER LAYER THICKNESS; SCANNING LASER OPHTHALMOSCOPY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISION; VISUAL ACUITY;

CATARACT SURGERY; NON-INSULIN-DEPENDENT DIABETES MELLITUS; OPTICAL COHERENCE TOMOGRAPHY; PHACOEMULSIFICATION; REPEATABILITY;

AGED; AGED, 80 AND OVER; CATARACT; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NERVE FIBERS; PHACOEMULSIFICATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84881517407     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-12390     Document Type: Article

References (40)

1. Maitra A, Abbas AK. Endocrine system. In: Kumar V, Fausto N, Abbas AK, eds. Robbins and Cotran Pathologic Basis of Disease. 7th ed. Philadelphia: Saunders; 2005:1156-1226.
2. Masharani U, German MS. Pancreatic hormones & diabetes mellitus. In: Gardner D, Shoback D, eds. Greenspan's Basic & Clinical Endocrinology. 9th ed. New York: McGraw-Hill Medical; 2011:573-656.
3. Ripsin CM, Kang H, Urban RJ. Management of blood glucose in type 2 diabetes mellitus. Am Fam Physician. 2009;79:29-36.
4. Hee MR, Puliafito CA, Wong C, et al. Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol. 1995;113:1019-1029.
5. Puliafito CA, Hee MR, Lin CP, et al. Imaging of macular diseases with optical coherence tomography. Ophthalmology. 1995; 102:217-229.
6. Akinci A, Muftuoglu O, Altinsoy A, Ozkilic E. Phacoemulsification with intravitreal bevacizumab and triamcinolone acetonide injection in diabetic patients with clinically significant macular edema and cataract. Retina. 2011;31:755-758.
7. Akinci A, Batman C, Ozkilic E, Altinsoy A. Phacoemulsification with intravitreal bevacizumab injection in diabetic patients with macular edema and cataract. Retina. 2009;29:1432- 1435.
8. Sivaprasad S, Gupta B, Crosby-Nwaobi R, Evans J. Prevalence of diabetic retinopathy in various ethnic groups: a worldwide perspective. Surv Ophthalmol. 2012;57:347-370.
9. Chalam KV, Bressler SB, Edwards AR, et al. Retinal thickness in people with diabetes and minimal or no diabetic retinopathy: Heidelberg Spectralis optical coherence tomography. Invest Ophthalmol Vis Sci. 2012;53:8154-8161.
10. Dhamdhere KP, Bearse MA Jr, Harrison W, Barez S, Schneck ME, Adams AJ. Associations between local retinal thickness and function in early diabetes. Invest Ophthalmol Vis Sci. 2012;53:6122-6128.
11. Na JH, Sung KR, Lee Y. Factors associated with the signal strengths obtained by spectral domain optical coherence tomography. J Ophthalmol. 2012;26:169-173.
12. Van Velthoven MEJ, Van der Linden MH, De Smet MD, Faber DJ, Verbraak FD. Influence of cataract on optical coherence tomography image quality and retinal thickness. Br J Ophthalmol. 2006;90:1259-1262.
13. Esmaeelpour M, Povazay B, Hermann B, et al. Threedimensional 1060-nm OCT: choroidal thickness maps in normal subjects and improved posterior segment visualization in cataract patients. Invest Ophthalmol Vis Sci. 2010;51:5260- 5266.
14. Cagini C, Fiore T, Iaccheri B, Piccinelli F, Ricci MA, Fruttini D. Macular thickness measured by optical coherence tomography in a healthy population before and after uncomplicated cataract phacoemulsification surgery. Curr Eye Res. 2009;34: 1036-1041.
15. Ghosh S, Roy I, Biswas PN, et al. Prospective randomized comparative study of macular thickness following phacoemulsification and manual small incision cataract surgery. Acta Ophthalmol. 2010;88:e102-e106.
16. Stock G, Ahlers C, Dunavoelgyi R, et al. Evaluation of anteriorsegment inflammation and retinal thickness change following cataract surgery. Acta Ophthalmol. 2011;89:369-375.
17. El-Ashry M, Appaswamy S, Deokule S, Pagliarini S. The effect of phacoemulsification cataract surgery on the measurement of retinal nerve fiber layer thickness using optical coherence tomography. Curr Eye Res. 2006;31:409-413.
18. Mwanza JC, Bhorade AM, Sekhon N, et al. Effect of cataract and its removal on signal strength and peripapillary retinal nerve fiber layer optical coherence tomography measurements. J Glaucoma. 2011;20:37-43.
19. Kim NR, Lee H, Lee ES, et al. Influence of cataract on time domain and spectral domain optical coherence tomography retinal nerve fiber layer measurements. J Glaucoma. 2012;21: 116-122.
20. Cheng CS, Natividad MG, Earnest A, et al. Comparison of the influence of cataract and pupil size on retinal nerve fibre layer thickness measurements with time-domain and spectraldomain optical coherence tomography. Clin Experiment Ophthalmol. 2011;39:215-221.
21. Akar Y, Orhan M, Irkec M. Reproducibility of the measurements of the optic nerve head topographic variables with a confocal scanning laser ophthalmoscope. Jpn J Ophthalmol. 2003;47:173-177.
22. Garcia-Martin E, Pueyo V, Pinilla I, Ara JR, Martin J, Fernandez J. Fourier-domain OCT in multiple sclerosis patients: reproducibility and ability to detect retinal nerve fiber layer atrophy. Invest Ophthalmol Vis Sci. 2011;52:4124-4131.
23. Vijan S. Type 2 diabetes. Ann Intern Med. 2010;152:ITC31-15.
24. Chylack LT Jr, Wolfe JK, Singer DM, et al. Longitudinal Study of Cataract Study Group. The Lens Opacities Classification System III. Arch Ophthalmol. 1993;111:831-836.
25. Kim JH, Kim NR, Lee ES, Rho S, Kang SY, Kim CY. Influence of blue light-filtering intraocular lenses on retinal nerve fiber layer measurements by spectral-domain optical coherence tomography. Curr Eye Res. 2011;36:937-942.
26. Schuman JS, Pedut-Kloizman T, Hertzmark E, et al. Reproducibility of nerve fiber layer thickness measurements using optical coherence tomography. Ophthalmology. 1996;103: 1889-1898.
27. Wu Z, Huang J, Dustin L, Sadda SR. Signal strength is an important determinant of accuracy of nerve fiber layer thickness measurement by optical coherence tomography. J Glaucoma. 2009;18:213-216.
28. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol. 1985;103:1796-1806.
29. Von Jagow B, Ohrloff C, Kohnen T. Macular thickness after uneventful cataract surgery determined by optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2007;245: 1765-1771.
30. Georgopoulos GT, Papaconstantinou D, Niskopoulou M, Moschos M, Georgalas I, Koutsandrea C. Foveal thickness after phacoemulsification as measured by optical coherence tomography. Clin Ophthalmol. 2008;2:817-820.
31. Kim SJ, Equi R, Bressler NM. Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography. Ophthalmology. 2007;114:881-889.
32. Kwon SI, Hwang DJ, Seo JY, Park IW. Evaluation of changes of macular thickness in diabetic retinopathy after cataract surgery. Korean J Ophthalmol. 2011;25:238-242.
33. Eriksson U, Alm A, Bjärnhall G, Granstam E, Matsson AW. Macular edema and visual outcome following cataract surgery in patients with diabetic retinopathy and controls. Graefes Arch Clin Exp Ophthalmol. 2011;249:349-359.
34. Katsimpris JM, Petropoulos IK, Zoukas G, Patokos T, Brinkmann CK, Theoulakis PE. Central foveal thickness before and after cataract surgery in normal and in diabetic patients without retinopathy. Klin Monbl Augenheilkd. 2012;229: 331-337.
35. Tsilimbaris M, Diakonis VF, Kymionis GD, et al. Prospective study of foveal thickness alterations after cataract surgery assessed by optical coherence tomography. Ophthalmologica. 2012;228:53-58.
36. Garcia-Martin E, Pinilla I, Sancho E, et al. Optical coherence tomography in retinitis pigmentosa: reproducibility and capacity to detect macular and retinal nerve fiber layer thickness alterations. Retina. 2012;32:1581-1591.
37. Garcia-Martin E, Satue M, Fuertes I, et al. Ability and reproducibility of fourier-domain optical coherence tomography to detect retinal nerve fiber layer atrophy in Parkinson's disease. Ophthalmology. 2012;119:2161-2167.
38. Degenring RF, Vey S, Kamppeter B, Budde WM, Jonas JB, Sauder G. Effect of uncomplicated phacoemulsification on the central retina in diabetic and non-diabetic subjects. Graefes Arch Clin Exp Ophthalmol. 2007;245:18-23.
39. Biró Z, Balla Z. OCT measurements on the foveal and perifoveal retinal thickness on diabetic patients after phacoemulsification and IOL implantation. Eye (Lond). 2010;24: 639-647.
40. Blumenthal EZ, Williams JM, Weinreb RN, Girkin CA, Berry CC, Zangwill LM. Reproducibility of nerve fiber layer thickness measurements by use of optical coherence tomography. Ophthalmology. 2000;107:2278-2282.